78 related articles for article (PubMed ID: 9602706)
1. Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer.
Singh S; Poulsom R; Hanby AM; Rogers LA; Wright NA; Sheppard MC; Langman MJ
J Pathol; 1998 Feb; 184(2):153-60. PubMed ID: 9602706
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer.
Singh S; Poulsom R; Wright NA; Sheppard MC; Langman MJ
Gut; 1997 Apr; 40(4):516-20. PubMed ID: 9176081
[TBL] [Abstract][Full Text] [Related]
3. Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer.
Singh S; Baker PR; Poulsom R; Wright NA; Sheppard MC; Langman MJ; Neoptolemos JP
Br J Surg; 1997 Aug; 84(8):1085-9. PubMed ID: 9278646
[TBL] [Abstract][Full Text] [Related]
4. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium.
Poulsom R; Hanby AM; Lalani EN; Hauser F; Hoffmann W; Stamp GW
J Pathol; 1997 Sep; 183(1):30-8. PubMed ID: 9370944
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors.
Saegusa M; Hashimura M; Hara A; Okayasu I
J Pathol; 2000 Apr; 190(5):554-63. PubMed ID: 10727981
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors.
Singh S; Sheppard MC; Langman MJ
Gut; 1993 May; 34(5):611-5. PubMed ID: 8504960
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of pS2 mRNA in breast cancer.
Wysocki SJ; Iacopetta BJ; Ingram DM
Eur J Cancer; 1994; 30A(12):1882-4. PubMed ID: 7880621
[TBL] [Abstract][Full Text] [Related]
9. Influence of steroid hormones on pS2/BCEI gene expression in xenografted colon tumors.
Theisinger B; Guthke R; Blin N; Welter C; Seitz G
In Vivo; 1993; 7(5):411-4. PubMed ID: 8110982
[TBL] [Abstract][Full Text] [Related]
10. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone receptors and pS2 and ERD5 antigens in gastric carcinomas from the European population.
Chaubert P; Bouzourene H; Saraga E
Mod Pathol; 1996 Mar; 9(3):189-93. PubMed ID: 8685212
[TBL] [Abstract][Full Text] [Related]
12. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression.
Lefebvre O; Wolf C; Kédinger M; Chenard MP; Tomasetto C; Chambon P; Rio MC
J Cell Biol; 1993 Jul; 122(1):191-8. PubMed ID: 8314841
[TBL] [Abstract][Full Text] [Related]
13. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
14. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells.
May FE; Westley BR
J Pathol; 1997 Aug; 182(4):404-13. PubMed ID: 9306961
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-associated protein pS2 expression in tumors of the biliary tract.
Seitz G; Thelsinger B; Tomasetto G; Rio MC; Chambon P; Blin N; Welter G
Am J Gastroenterol; 1991 Oct; 86(10):1491-4. PubMed ID: 1928043
[TBL] [Abstract][Full Text] [Related]
16. Detection of pS2 messenger RNA in gynecological cancers.
Wysocki SJ; Hahnel E; Masters A; Smith V; McCartney AJ; Hahnel R
Cancer Res; 1990 Mar; 50(6):1800-2. PubMed ID: 2306733
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.
Rio MC; Bellocq JP; Daniel JY; Tomasetto C; Lathe R; Chenard MP; Batzenschlager A; Chambon P
Science; 1988 Aug; 241(4866):705-8. PubMed ID: 3041593
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
McClelland RA; Manning DL; Gee JM; Willsher P; Robertson JF; Ellis IO; Blamey RW; Nicholson RI
Br J Cancer; 1998 May; 77(10):1653-6. PubMed ID: 9635843
[TBL] [Abstract][Full Text] [Related]
19. Trefoil peptide expression in intestinal adaptation and renewal.
Poulsom R; Chinery R; Sarraf C; Lalani EN; Stamp G; Elia G; Wright N
Scand J Gastroenterol Suppl; 1992; 192():17-28. PubMed ID: 1439565
[TBL] [Abstract][Full Text] [Related]
20. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma.
Welter C; Theisinger B; Seitz G; Tomasetto C; Rio MC; Chambon P; Blin N
Lab Invest; 1992 Feb; 66(2):187-92. PubMed ID: 1735955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]